HO-1 mRNA level in CML patients was significantly higher in comparison to donor samples, and its expression significantly increased in relapsing disease, indicating that HO-1 may be a potential molecular indicator for the progression of disease [188]. Here, HMOX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.